Navigation Links
Anti-retroviral drug conserving trial halted

The National Institute of Health has asked to stop SMART trial (Strategies for Management of Anti-retroviral Therapy) which is a trial on AIDS patients who are undergoing Anti-retroviral //therapy which recommends patients to have the drugs only when it is required contrasting to routine therapy which requires daily intake of these drugs.

The drug-conserving trial which is aimed at reducing the side effects of the drug and also helps economically by reducing the amount of money spent on AIDS drugs. The drug is recommended only when the CD4+ counts of the immune system of the patients gets reduced.

The SMART study had more than 5,000 study recruits from 33 countries and the NIH funded the drug conserving trial which it found would help the patients but NIH found that the patients who took off from the drug got more sicker than the patients who took anti-retroviral drugs daily. The results of the study made NIH to ask its collaborators to stop the trial immediately and as asked the patients to continue with daily medications.


'"/>




Page: 1

Related medicine news :

1. CMSI produces Low cost Anti-retroviral drugs in India
2. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
3. One Lakh HIV Patients to get Free Anti-retroviral Drugs by 2007
4. Mental Illness Reversed with Anti-retrovirals in HIV Cases
5. Man against HIV – new vaccine ready for human trials
6. Male contraceptive in trial
7. How do patients benefit of clinical trials
8. Glenmark’s new molecule to go through trial
9. Clinical trials need to be more frank
10. First head-to-head trials of once weekly Fosamax and Actonel therapies
11. Hormone Replacement Therapy increases the risk of endometrial cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, ... relations, content marketing, social media management, corporate communications, SEO and cause marketing, is ... and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a global data ... that Premier Research, a leading clinical development service provider, has selected ERT’s Trial ... complex, due in part to an array of circumstances including the use of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... CALNOC, the nation’s ... FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, ... and CEO of the Virginia Mason Health System in Seattle since 2000. In addition ...
(Date:2/23/2017)... ... , ... Carlos Gutierrez has lived his spiritual life hardly without ... is the purpose of everyone in this universe. As Gutierrez sees the need of ... attempts to guide readers to expand one’s spiritual life. , “Our Spiritual Truths” deals ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... CITY, Calif. , Feb. 23, 2017 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that it will release fourth ... on Thursday, March 2nd, 2017. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:2/23/2017)... COTTAGE, New York , February 23, 2017 /PRNewswire/ ... health implications arising from increasing caseload for varicose veins ... recorded across the globe are prompting the adoption of ... latest study on global endovenous laser therapy ... attention towards aftereffects of lifestyle choices and consequences of ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Endoscopy Market is poised to grow at ... approximately $47.6 billion by 2025. This industry report ... on global as well as regional levels presented in the research ...
Breaking Medicine Technology: